Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
177.00    3.00 (1.72%)
Bid:
176.60
Ask:
177.40
Spread: 0.80 (0.453%)
Market Cap: £430.48m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Chair Appointment

19 Apr 2024 08:51

RNS Number : 3197L
Sabre Insurance Group PLC
19 April 2024
 

19 April 2024

SABRE INSURANCE GROUP PLC

 

Chair Appointment

 

Sabre Insurance Group plc (the "Company" or "Sabre"), one of the UK's leading private motor insurance underwriters, is pleased to announce that Rebecca Shelley, who joined the Board as a Non-executive Director in December 2017, has been appointed as Chair of the Company. This is following an external search process and the receipt of regulatory approval from the PRA. The appointment takes place with immediate effect, as Rebecca has held the post on an interim basis since November 2023.

 

Rebecca has extensive commercial and financial services experience, having held several senior executive positions at Norwich Union plc, Prudential plc, Tesco plc and TP ICAP plc. Rebecca is currently the Senior Independent Director at both Liontrust Asset Management and Conduit Holdings Limited, and is the chair of the Remuneration and Sustainability committees at Hilton Food Group plc.

 

Commenting on her appointment, Rebecca Shelley said:

"I am delighted to have been appointed Chair of Sabre at a time when the Company continues to make excellent progress on its strategic objectives. I look forward to working with the Board and our management team to build on this progress as we continue to deliver for our customers and stakeholders".

 

Pursuant to Listing Rule 9.6.13R, it is confirmed there are no other disclosures required in addition to the above information.

 

For further information, please contact:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.uk

LEI Code: 2138006RXRQ8P8VKGV98

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGRGDSISBDGSC
Date   Source Headline
13th Aug 202412:48 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSHalf-year Report 2024
22nd Jul 20247:00 amRNSNotice of Results
11th Jul 202412:25 pmRNSDirector/PDMR Shareholding
3rd Jul 20243:40 pmRNSHolding(s) in Company
19th Jun 202412:28 pmRNSAppointment of Non-executive Director
14th Jun 20249:50 amRNSDirector/PDMR Shareholding
11th Jun 202411:54 amRNSDirector/PDMR Shareholding
11th Jun 202410:17 amRNSDirector/PDMR Shareholding
10th Jun 20244:16 pmRNSHolding(s) in Company
6th Jun 202412:52 pmRNSDirector/PDMR Shareholding
30th May 20242:00 pmRNSDirector/PDMR Shareholding
23rd May 202411:08 amRNSResult of AGM
23rd May 20247:00 amRNSTrading Update
22nd May 20241:59 pmRNSDirector/PDMR Shareholding
21st May 20242:46 pmRNSHolding(s) in Company
20th May 20248:23 amRNSAppointment of Senior Independent Director
15th May 20242:24 pmRNSHolding(s) in Company
13th May 202412:23 pmRNSDirector/PDMR Shareholding
23rd Apr 20244:00 pmRNSHolding(s) in Company
22nd Apr 20243:22 pmRNSHolding(s) in Company
19th Apr 20248:51 amRNSChair Appointment
18th Apr 202411:22 amRNSDirector Declaration
11th Apr 202412:41 pmRNSDirector/PDMR Shareholding
11th Apr 202412:07 pmRNSDirector/PDMR Shareholding
9th Apr 20242:44 pmRNSDirector/PDMR Shareholding
5th Apr 20243:48 pmRNSNotice of AGM
21st Mar 202412:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFull-year results 2023
13th Mar 20249:33 amRNSNotice of Results
12th Mar 20242:16 pmRNSDirector/PDMR Shareholding
12th Mar 202412:14 pmRNSDirector Declaration
16th Feb 20241:52 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTrading Statement
13th Feb 20242:18 pmRNSDirector/PDMR Shareholding
11th Jan 202411:11 amRNSDirector/PDMR Shareholding
20th Dec 20232:24 pmRNSHolding(s) in Company
12th Dec 202312:03 pmRNSDirector/PDMR Shareholding
28th Nov 20234:27 pmRNSDirectorate Change
27th Nov 20234:42 pmRNSRemuneration Committee Chair Appointment
22nd Nov 20238:51 amRNSNotification of cyber incident
20th Nov 20237:00 amRNSDeath of Chair
13th Nov 202311:44 amRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSTrading Update
11th Oct 202312:52 pmRNSDirector/PDMR Shareholding
25th Sep 20233:39 pmRNSDirector/PDMR Shareholding
21st Sep 202311:48 amRNSDirector/PDMR Shareholding
14th Sep 20232:25 pmRNSHolding(s) in Company
13th Sep 202310:00 amRNSDirector/PDMR Shareholding
13th Sep 20239:33 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.